Neurostimulator clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 12-17
To demonstrate that the RNS System is safe and effective as an adjunctive therapy in individuals age 12 through 17 years with medically refractory partial onset epilepsy.
Our lead scientists for Neurostimulator research studies include Joyce Matsumoto.